Detailed explanation of domestic medical insurance coverage and price of cycloserine

Cycloserine (Cycloserine), an antibiotic that plays an important role in anti-tuberculosis treatment, has become a powerful assistant in the treatment of tuberculosis and other bacterial infections since it was successfully isolated from actinomycetes in 1952.

Cycloserine is unique in its chemical structure and mechanism of action. As an amino acid derivative, it belongs to the β- lactam antibiotics. By competitively inhibiting D-alanine-D-alanine ligase, cycloserine effectively prevents the cross-linking of peptidoglycan, interferes with bacterial cell wall synthesis, and ultimately leads to bacterial death. This mechanism allows cycloserine to show significant activity against a variety of drug-resistant strains, especially playing a pivotal role in the treatment of multidrug-resistant tuberculosis (MDR-TB).

In clinical practice, cycloserine is often used as a second-line drug, especially in patients who are resistant to first-line anti-tuberculosis drugs such as isoniazid and rifampicin. It is well absorbed after oral administration and can quickly penetrate into various tissues and body fluids of the human body, including the lungs and cerebrospinal fluid, making it effective in treating infections such as tuberculosis and tuberculous meningitis.

However, the use of cycloserine is not without risks. Patients may experience a series of central nervous system symptoms during use, such as headache, dizziness, insomnia, depression and anxiety, and may even trigger epilepsy and psychotic symptoms. Therefore, when using cycloserine for treatment, patients must be under the close supervision of a doctor so that the doctor can adjust the dose or discontinue the drug in a timely manner to ensure the patient's safety.

Talking about price and medical insurance, cycloserine is currently on the market in China and has been included in the medical insurance catalog, providing patients with convenience in purchasing and using it. This means that patients can reimburse part of the expenses through medical insurance and reduce their financial burden. The specification of domestic cycloserine is usually 250mg*10 tablets, and the price is about a few hundred yuan. Due to differences in medical insurance policies in various places, patients need to consult the local hospital pharmacy for specific reimbursement ratios and self-pay portions to obtain accurate information.

In addition, foreign markets, especially India, also provide the supply of cycloserine, and the price is relatively affordable. The specifications of generic drugs produced in India are 250mg*60 tablets, and the price is about 600 yuan. These generic drugs have basically the same ingredients as domestic drugs, providing patients with more choices and affordable ways to purchase drugs.